A homoallelic Gly[sup 317] [yields] Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian mennonites
- Univ. of Manitoba, Winnepeg (Canada)
The authors have discovered a single homoallelic nucleotide substitution as the putative cause of the perinatal (lethal) form of hypophosphatasia in Canadian Mennonites. Previous linkage and haplotype analysis in this population suggested that a single mutational event was responsible for this autosomal recessive form of hypophosphatasia. The mutation is a guanosine-to-adenosine substitution at nucleotide position 1177 in exon 10 of the tissue nonspecific (liver/bone/kidney) alkaline phosphatase gene. This Gly[sup 317] [yields] Asp mutation segregates exclusively with the heterozygote phenotype previously assigned by biochemical testing (maximum combined lod score of 18.24 at [theta] = 0.00). This putative disease-causing mutation has not been described in controls nor in other non-Mennonite probands with both lethal and nonlethal forms of hypophosphatasia studied to date. This Gly[sup 317] [yields] Asp mutation changes a polar glycine to an acidic aspartate at amino acid position 317 within the highly conserved active site region of the 507-amino-acid polypeptide. Carrier screening for this lethal mutation in a high-risk population is now feasible. 15 refs., 2 figs.
- OSTI ID:
- 6955778
- Journal Information:
- Genomics; (United States), Vol. 17:1; ISSN 0888-7543
- Country of Publication:
- United States
- Language:
- English
Similar Records
Molecular analyses of a tyrosinase-negative albino family
High-resolution NMR studies of fibrinogen-like peptides in solution: Structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A. alpha. chain of human fibrinogen Rouen